Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2006 1
2008 1
2009 1
2010 2
2019 1
2020 2
2021 3
2022 2
2024 1
2025 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

10 results

Results by year

Filters applied: . Clear all
Page 1
Did you mean stift j (71 results)?
Efficacy and safety of mirikizumab in patients with moderately-to-severely active Crohn's disease: a phase 3, multicentre, randomised, double-blind, placebo-controlled and active-controlled, treat-through study.
Ferrante M, D'Haens G, Jairath V, Danese S, Chen M, Ghosh S, Hisamatsu T, Kierkus J, Siegmund B, Bragg SM, Crandall W, Durand F, Hon E, Lin Z, Lopes MU, Morris N, Protic M, Carlier H, Sands BE; VIVID Study Group. Ferrante M, et al. Lancet. 2024 Dec 14;404(10470):2423-2436. doi: 10.1016/S0140-6736(24)01762-8. Epub 2024 Nov 21. Lancet. 2024. PMID: 39581202 Clinical Trial.
Etrolizumab as induction and maintenance therapy for ulcerative colitis in patients previously treated with tumour necrosis factor inhibitors (HICKORY): a phase 3, randomised, controlled trial.
Peyrin-Biroulet L, Hart A, Bossuyt P, Long M, Allez M, Juillerat P, Armuzzi A, Loftus EV Jr, Ostad-Saffari E, Scalori A, Oh YS, Tole S, Chai A, Pulley J, Lacey S, Sandborn WJ; HICKORY Study Group. Peyrin-Biroulet L, et al. Lancet Gastroenterol Hepatol. 2022 Feb;7(2):128-140. doi: 10.1016/S2468-1253(21)00298-3. Epub 2021 Nov 17. Lancet Gastroenterol Hepatol. 2022. PMID: 34798039 Free article. Clinical Trial.
Etrolizumab for maintenance therapy in patients with moderately to severely active ulcerative colitis (LAUREL): a randomised, placebo-controlled, double-blind, phase 3 study.
Vermeire S, Lakatos PL, Ritter T, Hanauer S, Bressler B, Khanna R, Isaacs K, Shah S, Kadva A, Tyrrell H, Oh YS, Tole S, Chai A, Pulley J, Eden C, Zhang W, Feagan BG; LAUREL Study Group. Vermeire S, et al. Lancet Gastroenterol Hepatol. 2022 Jan;7(1):28-37. doi: 10.1016/S2468-1253(21)00295-8. Epub 2021 Nov 17. Lancet Gastroenterol Hepatol. 2022. PMID: 34798037 Clinical Trial.
The effect of aspirin and vitamins C and E on HbA1c assays.
Camargo JL, Stifft J, Gross JL. Camargo JL, et al. Among authors: stifft j. Clin Chim Acta. 2006 Oct;372(1-2):206-9. doi: 10.1016/j.cca.2006.03.031. Epub 2006 May 15. Clin Chim Acta. 2006. PMID: 16698007 Clinical Trial.
Potential roles of Helicobacter pylori treatment, body mass index and waist circumference in the causation of erosive esophagitis: a randomized clinical trial (HEROES-GERD).
Mazzoleni F, Mazzoleni LE, de Magalhães Francesconi CF, Sander GB, Von Reisswitz PS, Milbradt TC, da Veiga Chaves Picon R, Uchoa DM, De Bona LR, Andreolla HF, Breyer HP, Spinato Torresini R, Ott EA, Wortmann AC, de Lucena Theil A, Stifft J, Zenker RP, Krumel CF, Michalczuk MT, De Araujo A, Canevese AP, Volpato N, da Silva CA, Schaefer PG, Titton NF, Longo L, Edelweiss MI, Simon D, Talley NJ. Mazzoleni F, et al. Among authors: stifft j. Int J Obes (Lond). 2020 Jan;44(1):147-158. doi: 10.1038/s41366-019-0391-3. Epub 2019 Jun 13. Int J Obes (Lond). 2020. PMID: 31197249 Clinical Trial.
Analysis of the Influence of Interleukin-1β Gene Polymorphism on Gastric Inflammatory Response and Precancerous Lesions Development in Patients with Functional Dyspepsia.
Rech TF, Mazzoleni LE, Mazzoleni F, Francesconi CFM, Sander GB, Michita RT, Nabinger DD, de Bona LR, Milbradt TC, Ott EA, Breyer HP, Haas GM, Canevese AP, Stifft J, Simon D. Rech TF, et al. Among authors: stifft j. Immunol Invest. 2020 Jul;49(5):585-596. doi: 10.1080/08820139.2019.1710532. Epub 2020 Jan 7. Immunol Invest. 2020. PMID: 31909646